Molecular Insight of Mangiferin in Cancer Chemoprevention: A Review Article
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Cancer is a public health problem causing one in six deaths globally. Fighting cancer has always been challenging, leading to an evolution in cancer therapies. Mangiferin, a bioactive component found in honeybush tea and mangoes, is a chemotherapeutic and chemopreventive drug against many cancers. This review addresses the critical need for alternative and cost-effective cancer treatments in developing countries, which bear 57% of new cancer cases and 65% of cancer-related deaths globally. A non-systematic search was conducted using research engines such as MEDLINE, Scopus, PMC, Embase, PubMed, Web of Science, and Google Scholar. More than 250 studies have been carried out on Mangiferin between 2001 and 2021, including clinical trials for cancer treatment. Mangiferin demonstrates significant anticancer activity by suppressing malignant proliferation across multiple cancer cell lines, including CCD-18Co, LNCaP, MCF-7, OVCAR3, HeLa, HepG2, MDA-MB-231, A549, and others. The compound targets diverse molecular pathways involved in proliferation, apoptosis evasion, metastasis, and angiogenesis, including NF-kB, MMPs, COX-2, FGF, VEGF, and ICAM. Additionally, Mangiferin exhibits chemopreventive properties and synergizes with conventional anticancer agents. However, its clinical translation is hindered by poor oral bioavailability (
Fields of Study & Subjects
Mangiferin and Mango Extracts
Natural Compound Pharmacology Studies
Bioactive natural compounds
Publication details
- Journal / source
- Pakistan BioMedical Journal
- Pages
- 03–11
- Publication date
- 28 February 2026
- Language
- EN